INKT Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)-0.62
Revenue Actual (USD)--
Mink Therapeutics Inc Earnings Dates & Reports
This page offers detailed Mink Therapeutics Inc earnings data including the latest Mink Therapeutics Inc earnings report, the upcoming Mink Therapeutics Inc earnings date, historical data and Mink Therapeutics Inc earnings call news.
INKT Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
INKT FY2025 Earnings
EPS (YoY)-2.9389.76%
Revenue (YoY)----
Mink Therapeutics Inc (INKT) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -0.62/-0.60 | --/0.00 | -3.79% | -- |
| 5/15/2026 | 03/2026 | -0.57/-0.77 | --/0.00 | 25.77% | -- |
| 3/31/2026 | 12/2025 | -0.56/-0.82 | --/0.00 | 32.29% | -- |
| 11/14/2025 | 09/2025 | -0.65/-0.85 | --/0.00 | 23.99% | -- |
| 8/14/2025 | 06/2025 | -1.06/-0.55 | --/0.00 | -94.68% | -- |
| 5/15/2025 | 03/2025 | -0.70/-0.61 | --/0.00 | -14.39% | -- |
| 3/18/2025 | 12/2024 | -0.62/-0.50 | --/0.00 | -24.44% | -- |
| 11/14/2024 | 09/2024 | -0.46/-0.80 | --/-- | 42.88% | -- |
Mink Therapeutics Inc Latest Earnings Call Transcripts
MiNK Therapeutics (INKT) Q2 2026 Earnings Call: agenT-797 ARDS Trial Advances
MiNK Therapeutics Q2 2026 earnings call: net loss narrowed to $3.1 million, cash ended at $8.8 million, and agenT-797 Phase 2 ARDS data are due in early 2027.